PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Launch of Indian public health standards for Ayush healthcare facilities
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Cipla completes transfer of Generics Business Undertaking
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
